Furthermore, Hsp90 inhibitor treatment of classical Hodgkin lymphoma cells was shown to cause inhibition of STAT1, -3, -5, -6 tyrosine phosphorylation probably as a result of decreased expression and phosphorylation of JAK family members [39]. This evidence concerns the gene STAT1 and Hodgkins lymphoma.